August 19th, 2006
According to a new study published in the August 16 issue of the Journal of the National Cancer Institute, breast cancer patients aged 63 years or younger may experience more chemotherapy-related serious adverse effects than reported in clinical trials.
Such were the findings of researchers from Dana-Farber Cancer Institute and Harvard Medical School that studied 7,052 […]
By Gloria Gamat -- 0 comments
August 18th, 2006
While nanotechnology is revolutionizing the world, its biggest impact in the future would be in the healthcare industry.
In a collaboration of Rush University Medical Center with Argonne National Laboratory and the Illinois Institute of Technology, nanotechnology is being utilized in searching for new ways to diagnose and treat ovarian cancer.
“While the mortality rates of many […]
By Gloria Gamat -- 0 comments
August 17th, 2006
While the anti-cancer compounds found in broccoli has been much studied, a new research suggests that more pure active compounds can be extracted from woad, a member of the same brassica plant family is a source of blue dye – a dye used in Neolithic times as paint in the faces of warriors to scare […]
By Gloria Gamat -- 0 comments
August 16th, 2006
Increased levels of the oncogene HER-2 are associated with poor patient prognosis, enhanced metastasis (cancer spread) and resistance to chemotherapy.
Herceptin (trastuzumab) is the monoclonal antibody used in combination with certain cancer chemotherapies.
Researchers from the Northwestern University and Evanston Northwestern Healthcare found that Herceptin effectively treats breast cancer tumors that produce low or undetectable amounts […]
By Gloria Gamat -- 0 comments
August 14th, 2006
PLK1 is a protein that keeps prostate cancer cells alive.
Duke University Medical Center has tested an experimental gene-based drug in mice with prostate cancer and found that it shrank the size of their tumors by 50% without causing side effects.
The RNA-drug, a first of its kind, utilizes a type of genetic material called “targeting RNA” […]
By Gloria Gamat -- 0 comments
August 14th, 2006
DES daughters, those born to mothers who used the anti-miscarriage drug diethylstilbestrol during pregnancy, are at a significantly greater risk of developing breast cancer than women who were not exposed to the drug in utero.
This finding has been reported in the August issue of the journal Cancer Epidemiology, Biomarkers & Prevention, which found that DES […]
By Gloria Gamat -- 0 comments
August 13th, 2006
Oxy-Q, a proprietary pill by Farr Laboratories, LLC that combines the active components of turmeric and onions, in a pilot clinical trial has been shown to reduce both the size and number of precancerous colon polyps.
The study used the unique blend of curcumin found in turmeric and quercetin found in onions and green tea, […]
By Gloria Gamat -- 1 comment
August 11th, 2006
Focus Surgery, Inc. has recently received a provisional Investigational Device Exemption (IDE) from the USFDA for its Sonablate® 500 that will allow the device to be used in a multicenter clinical study to collect safety and efficacy data for final USFDA approval.
The said clinical study, which will enroll some 466 subjects in 24 institutuions, will […]
By Gloria Gamat -- 0 comments
August 10th, 2006
It might already be cliché to read or write about eating plenty of fruits and vegetables.
But looking at colorectal cancer statistics (363,000 new cases/per in Europe, estimated 945,000 globally, some 492,000 deaths/year) will scare many people and I guess we all will eat more fruits and vegetables if we’re told the doing so will lessen […]
By Gloria Gamat -- 1 comment
August 7th, 2006
Myriad Genetics, Inc. (Nasdaq: MYGN), maker of molecular diagnostic products, has introduced into the market its BRACAnalysis® Rearrangement Test, a new molecular diagnostic test added in the BRACAnalysis family of products.
This additional test detects rare, large rearrangements of the DNA in the BRCA1 and BRCA2 genes and will be performed for women with exceptionally high […]
By Gloria Gamat -- 0 comments
Recent Comments